Cresco Labs plans to sell California operations in strategic restructuring

July 21, 2025 6:30 AM EDT

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced plans to divest its California cannabis operations as part of a strategic restructuring aimed at strengthening its balance sheet and increasing cash flow, according to a company press release.



The Chicago-based cannabis company is in discussions with prospective buyers interested in acquiring its California assets, including cultivation, manufacturing, and select distribution operations. The company expects to complete the transaction within the next several quarters, subject to closing conditions and regulatory approvals.



Cresco Labs will retain ownership of its FloraCal brand and continue producing and marketing the brand across other U.S. markets following the divestiture.



"Capital is increasingly precious in this environment, and our focus is on deploying it where it earns the strongest return," said Charlie Bachtell, CEO and Co-founder of Cresco Labs. "While California is the largest cannabis market in the world, the structural challenges—ranging from fragmented retail to price compression and the illicit market—combined with our lack of scaled footprint in the state, make it extremely difficult to generate sustainable profitability."



The restructuring represents the company's strategy to prioritize markets with higher margins and long-term growth potential. Bachtell stated that exiting California will allow the company to reallocate capital and resources to core markets and build out new markets with clearer pathways for growth.



Cresco Labs operates cannabis cultivation, production, and branded product distribution, along with Sunnyside-branded dispensaries. The company's brand portfolio includes Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's, and Remedi.


You May Also Be Interested In





Related Categories

Corporate News, Hot Corp. News